Artykuły w czasopismach na temat „Estrogen Therapeutic use”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Estrogen Therapeutic use”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Fillit, Howard. "Future Therapeutic Developments of Estrogen Use". Journal of Clinical Pharmacology 35, nr 9S (wrzesień 1995): 25S—28S. http://dx.doi.org/10.1002/j.1552-4604.1995.tb04144.x.
Pełny tekst źródłaMartin-Jiménez, Cynthia, Diana Milena Gaitán-Vaca, Natalia Areiza, Valentina Echeverria, Ghulam Md Ashraf, Janneth González, Amirhossein Sahebkar, Luis Miguel Garcia-Segura i George E. Barreto. "Astrocytes Mediate Protective Actions of Estrogenic Compounds after Traumatic Brain Injury". Neuroendocrinology 108, nr 2 (4.11.2018): 142–60. http://dx.doi.org/10.1159/000495078.
Pełny tekst źródłaSanten, Richard J., Risa Kagan, Corrado J. Altomare, Barry Komm, Sebastian Mirkin i Hugh S. Taylor. "Current and Evolving Approaches to Individualizing Estrogen Receptor-Based Therapy for Menopausal Women". Journal of Clinical Endocrinology & Metabolism 99, nr 3 (1.03.2014): 733–47. http://dx.doi.org/10.1210/jc.2013-3680.
Pełny tekst źródłaMacciò, Antonio, i Clelia Madeddu. "Obesity, Inflammation, and Postmenopausal Breast Cancer: Therapeutic Implications". Scientific World JOURNAL 11 (2011): 2020–36. http://dx.doi.org/10.1100/2011/806787.
Pełny tekst źródłaMitra, Saikat, Mashia Subha Lami, Avoy Ghosh, Rajib Das, Trina Ekawati Tallei, Fatimawali, Fahadul Islam i in. "Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?" Cancers 14, nr 3 (1.02.2022): 759. http://dx.doi.org/10.3390/cancers14030759.
Pełny tekst źródłaGérard, Céline, Mélanie Mestdagt, Ekaterine Tskitishvili, Laudine Communal, Anne Gompel, Elisabete Silva, Jean-François Arnal i in. "Combined Estrogenic and Antiestrogenic Properties of Estetrol on Breast Cancer may provide a Safe Therapeutic Window for the Treatment of Menopausal Symptoms". Journal of SAFOMS 3, nr 1 (2015): 31–33. http://dx.doi.org/10.5005/jsafoms-3-1-31.
Pełny tekst źródłaHwang, Wu Jeong, Tae Young Lee, Nahrie Suk Kim i Jun Soo Kwon. "The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders". International Journal of Molecular Sciences 22, nr 1 (31.12.2020): 373. http://dx.doi.org/10.3390/ijms22010373.
Pełny tekst źródłaZhao, Zhuo, Hao Wang, Jewell A. Jessup, Sarah H. Lindsey, Mark C. Chappell i Leanne Groban. "Role of estrogen in diastolic dysfunction". American Journal of Physiology-Heart and Circulatory Physiology 306, nr 5 (1.03.2014): H628—H640. http://dx.doi.org/10.1152/ajpheart.00859.2013.
Pełny tekst źródłaFarkas, Szidónia, Adrienn Szabó, Anita Emőke Hegyi, Bibiána Török, Csilla Lea Fazekas, Dávid Ernszt, Tamás Kovács i Dóra Zelena. "Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions". Biomedicines 10, nr 4 (6.04.2022): 861. http://dx.doi.org/10.3390/biomedicines10040861.
Pełny tekst źródłaSulaymanova, R. T. "EXPERIMENTAL MODELS OF TRANSGENERATIONAL EFFECTS OF THE INFLUENCE OF ESTROGENS ON THE MORPHOLOGY OF REPRODUCTIVE ORGANS IN POSTNATAL ONTOGENESIS". Morphological newsletter 27, nr 1 (30.03.2019): 36–44. http://dx.doi.org/10.20340/mv-mn.19(27).01.36-44.
Pełny tekst źródłaNormanno, Nicola, Massimo Di Maio, Ermelinda De Maio, Antonella De Luca, Andrea de Matteis, Antonio Giordano, Francesco Perrone i _. _. "Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer". Endocrine-Related Cancer 12, nr 4 (grudzień 2005): 721–47. http://dx.doi.org/10.1677/erc.1.00857.
Pełny tekst źródłaElloso, M. Merle, Kristen Phiel, Ruth A. Henderson, Heather A. Harris i Steven J. Adelman. "Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands". Journal of Endocrinology 185, nr 2 (maj 2005): 243–52. http://dx.doi.org/10.1677/joe.1.06063.
Pełny tekst źródłaManyonda, Isaac, Vikram S Talaulikar, Roxanna Pirhadi i Joseph Onwude. "Progestogens are the problem in hormone replacement therapy: Time to reappraise their use". Post Reproductive Health 26, nr 1 (25.12.2019): 26–31. http://dx.doi.org/10.1177/2053369119876490.
Pełny tekst źródłaCarroll, Kelli J., Michael C. Dovey, Claire C. Cutting, James M. Harris, Lea M. Vedder, Wolfram Goessling i Trista E. North. "Estrogen Receptors 1 and 2 Have Stage-Specific Effects on Hematopoietic Stem Cell Regulation In Zebrafish." Blood 116, nr 21 (19.11.2010): 1617. http://dx.doi.org/10.1182/blood.v116.21.1617.1617.
Pełny tekst źródłaPetrie, Whitney K., Megan K. Dennis, Chelin Hu, Donghai Dai, Jeffrey B. Arterburn, Harriet O. Smith, Helen J. Hathaway i Eric R. Prossnitz. "G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth". Obstetrics and Gynecology International 2013 (2013): 1–17. http://dx.doi.org/10.1155/2013/472720.
Pełny tekst źródłaYakushevskaya, O. V. "Continuous combined low-dose hormone replacement therapy in perimenopause: an algorithm of choice". Meditsinskiy sovet = Medical Council, nr 3 (15.04.2021): 113–18. http://dx.doi.org/10.21518/2079-701x-2021-3-113-118.
Pełny tekst źródłaCarroll, Kelli J., Michael C. Dovey, Claire C. Cutting, Lea Vedder Sheward, James M. Harris, Wolfram Goessling i Trista E. North. "Hematopoietic Stem Cell Formation in Zebrafish Is Regulated in a Temporally Distinct Manner by Estrogen Receptor 2". Blood 118, nr 21 (18.11.2011): 1268. http://dx.doi.org/10.1182/blood.v118.21.1268.1268.
Pełny tekst źródłaKareva, Kareva E. N., i Smetnik A. A. Smetnik. "Estrogen-like and antioxidant properties of resveratrol in clinical pharmacology and therapeutic use". Akusherstvo i ginekologiia 12_2021 (24.12.2021): 37–48. http://dx.doi.org/10.18565/aig.2021.12.37-48.
Pełny tekst źródłaAcharya, Asha, Ila Das, Des Chandhok i Tapas Saha. "Redox Regulation in Cancer: A Double-edged Sword with Therapeutic Potential". Oxidative Medicine and Cellular Longevity 3, nr 1 (2010): 23–34. http://dx.doi.org/10.4161/oxim.3.1.10095.
Pełny tekst źródłaCompston, Juliet E. "Sex Steroids and Bone". Physiological Reviews 81, nr 1 (1.01.2001): 419–47. http://dx.doi.org/10.1152/physrev.2001.81.1.419.
Pełny tekst źródłaBenagiano, Giuseppe, i Ivo Brosens. "The Endometrium in Adenomyosis". Women's Health 8, nr 3 (maj 2012): 301–12. http://dx.doi.org/10.2217/whe.12.8.
Pełny tekst źródłaVelez, Maria A., Timothy F. Burns i Laura P. Stabile. "The estrogen pathway as a modulator of response to immunotherapy". Immunotherapy 11, nr 13 (wrzesień 2019): 1161–76. http://dx.doi.org/10.2217/imt-2019-0024.
Pełny tekst źródłaKuznetsova, I. V. "Transition period of estrogen-progestogen hormone therapy". Medical alphabet 3, nr 25 (19.11.2019): 6–10. http://dx.doi.org/10.33667/2078-5631-2019-3-25(400)-6-10.
Pełny tekst źródłaBiggar, Robert J. "Molecular Pathways: Digoxin Use and Estrogen-Sensitive Cancers—Risks and Possible Therapeutic Implications: Figure 1." Clinical Cancer Research 18, nr 8 (24.02.2012): 2133–37. http://dx.doi.org/10.1158/1078-0432.ccr-11-1389.
Pełny tekst źródłaZhao, Hong, Ling Zhou, Anna Junjie Shangguan i Serdar E. Bulun. "Aromatase expression and regulation in breast and endometrial cancer". Journal of Molecular Endocrinology 57, nr 1 (lipiec 2016): R19—R33. http://dx.doi.org/10.1530/jme-15-0310.
Pełny tekst źródłaFoster, Paul A., L. W. Lawrence Woo, Barry V. L. Potter, Michael J. Reed i Atul Purohit. "The Use of Steroid Sulfatase Inhibitors as a Novel Therapeutic Strategy Against Hormone-Dependent Endometrial Cancer". Endocrinology 149, nr 8 (1.05.2008): 4035–42. http://dx.doi.org/10.1210/en.2008-0223.
Pełny tekst źródłaZhao, Liqin, Zisu Mao i Roberta Diaz Brinton. "A Select Combination of Clinically Relevant Phytoestrogens Enhances Estrogen Receptor β-Binding Selectivity and Neuroprotective Activities in Vitro and in Vivo". Endocrinology 150, nr 2 (1.02.2009): 770–83. http://dx.doi.org/10.1210/en.2008-0715.
Pełny tekst źródłaKuznetsova, I. V., L. V. Evsyukova i V. A. Konovalov. "Combined oral contraception: is there a resource for increased use?" Medical Council, nr 12 (29.07.2018): 146–51. http://dx.doi.org/10.21518/2079-701x-2018-12-146-151.
Pełny tekst źródłaGucalp, Ayca, i Tiffany A. Traina. "Triple-Negative Breast Cancer: Adjuvant Therapeutic Options". Chemotherapy Research and Practice 2011 (21.06.2011): 1–13. http://dx.doi.org/10.1155/2011/696208.
Pełny tekst źródłaHahn, S. E., L. A. da Cruz, D. Sayegh, A. Ferry, K. O’Reilly, D. S. Pereira, D. B. Rubinstein, H. Findlay i D. S. Young. "Therapeutic monoclonal antibodies target phenotypically-differing human breast cancer". Journal of Clinical Oncology 25, nr 18_suppl (20.06.2007): 13510. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.13510.
Pełny tekst źródłaMonaco, Alessandra, Fabrizio Licitra, Martina Di Gisi, Giovanni Galasso, Marzia Di Donato, Pia Giovannelli, Antimo Migliaccio i Gabriella Castoria. "ERβ in Triple-Negative Breast Cancer: Emerging Concepts and Therapeutic Possibilities". Endocrines 2, nr 3 (13.09.2021): 356–65. http://dx.doi.org/10.3390/endocrines2030033.
Pełny tekst źródłashen, Tian, Helia Nasrollahi Sanchez, Hong Zan i Paolo Casali. "Short-chain fatty acid HDAC inhibitor-mediated downregulation of AID expression and class switch DNA recombination is relieved by estrogen through modulation of selected microRNAs". Journal of Immunology 196, nr 1_Supplement (1.05.2016): 127.12. http://dx.doi.org/10.4049/jimmunol.196.supp.127.12.
Pełny tekst źródłaCannataro, Roberto, i Erika Cione. "Nutritional Supplements and Lipedema: Scientific and Rational Use". Nutraceuticals 2, nr 4 (3.10.2022): 270–77. http://dx.doi.org/10.3390/nutraceuticals2040020.
Pełny tekst źródłaKim, Kyung Hee, Derek Toomre i Jeffrey R. Bender. "Splice isoform estrogen receptors as integral transmembrane proteins". Molecular Biology of the Cell 22, nr 22 (15.11.2011): 4415–23. http://dx.doi.org/10.1091/mbc.e11-05-0416.
Pełny tekst źródłaChen, Shuhua, Jon Nilsen i Roberta Diaz Brinton. "Dose and Temporal Pattern of Estrogen Exposure Determines Neuroprotective Outcome in Hippocampal Neurons: Therapeutic Implications". Endocrinology 147, nr 11 (1.11.2006): 5303–13. http://dx.doi.org/10.1210/en.2006-0495.
Pełny tekst źródłaYukalchuk, D. Yu, D. M. Ponomarenko, T. N. Yukalchuk, S. S. Sidorova, A. V. Shevchuk i A. M. Novopashin. "The Use of Alpelisib in Metastatic Estrogen-Receptor-Positive HER2/Neu-Negative Breast Cancer". Effective Pharmacotherapy 18, nr 13 (25.04.2022): 121–16. http://dx.doi.org/10.33978/2307-3586-2022-18-13-12-16.
Pełny tekst źródłaOualla, Karima, Heba M. El-Zawahry, Banu Arun, James M. Reuben, Wendy A. Woodward, Heba Gamal El-Din, Bora Lim, Nawfel Mellas, Naoto T. Ueno i Tamer M. Fouad. "Novel therapeutic strategies in the treatment of triple-negative breast cancer". Therapeutic Advances in Medical Oncology 9, nr 7 (13.06.2017): 493–511. http://dx.doi.org/10.1177/1758834017711380.
Pełny tekst źródłaBitirim, Ceylan V., Zeynep B. Ozer i Kamil C. Akcali. "Estrogen receptor alpha regulates the expression of adipogenic genes genetically and epigenetically in rat bone marrow-derived mesenchymal stem cells". PeerJ 9 (10.09.2021): e12071. http://dx.doi.org/10.7717/peerj.12071.
Pełny tekst źródłaGhuge, Rahul B., Prashant R. Murumkar, Kailash M. Choudhary, Karan D. Joshi, Monica Chauhan, Rahul R. Barot i Mange R. Yadav. "Development of Steroidal Aromatase Inhibitors as Potential Anti-breast Cancer Agents". Current Enzyme Inhibition 16, nr 1 (4.05.2020): 45–62. http://dx.doi.org/10.2174/1573408016666200212094804.
Pełny tekst źródłaDowns, William V., Edward L. Perkins, William E. Burak i Himangshu S. Bose. "ODP433 An increased in AIPB expression in Triple Negative (ER-/PR-/Her2-) Breast Tumors reduces estradiol synthesis". Journal of the Endocrine Society 6, Supplement_1 (1.11.2022): A671. http://dx.doi.org/10.1210/jendso/bvac150.1388.
Pełny tekst źródłaWu, Malinda, Neha Arora, Viranuj Sueblinvong, William R. Hunt i Vin Tangpricha. "Estrogen Supplementation Is Associated With Higher Quality of Life Scores in Women With Cystic Fibrosis". Journal of the Endocrine Society 5, Supplement_1 (1.05.2021): A732. http://dx.doi.org/10.1210/jendso/bvab048.1489.
Pełny tekst źródłaVorobiof, Daniel A. "Recent advances in the medical treatment of breast cancer". F1000Research 5 (29.11.2016): 2786. http://dx.doi.org/10.12688/f1000research.9619.1.
Pełny tekst źródłaGunther, Jillian R., Yuhong Du, Eric Rhoden, Iestyn Lewis, Brian Revennaugh, Terry W. Moore, Sung Hoon Kim, Raymond Dingledine, Haian Fu i John A. Katzenellenbogen. "A Set of Time-Resolved Fluorescence Resonance Energy Transfer Assays for the Discovery of Inhibitors of Estrogen Receptor-Coactivator Binding". Journal of Biomolecular Screening 14, nr 2 (luty 2009): 181–93. http://dx.doi.org/10.1177/1087057108329349.
Pełny tekst źródłaLi, Ang. "An Overview of Tumor Necrosis Factor-α on Pathophysiological Mechanisms, Relevant Therapeutic Status in Breast Cancer". Highlights in Science, Engineering and Technology 8 (17.08.2022): 472–80. http://dx.doi.org/10.54097/hset.v8i.1201.
Pełny tekst źródłaRay, Rinki, Christine M. Herring, Troy A. Markel, Paul R. Crisostomo, Meijing Wang, Brent Weil, Tim Lahm i Daniel R. Meldrum. "Deleterious effects of endogenous and exogenous testosterone on mesenchymal stem cell VEGF production". American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 294, nr 5 (maj 2008): R1498—R1503. http://dx.doi.org/10.1152/ajpregu.00897.2007.
Pełny tekst źródłaThabet, Romany H., Adel A. Gomaa, Laila M. Matalqah i Erin M. Shalaby. "Vitamin D: an essential adjuvant therapeutic agent in breast cancer". Journal of International Medical Research 50, nr 7 (lipiec 2022): 030006052211138. http://dx.doi.org/10.1177/03000605221113800.
Pełny tekst źródłaKomal S, Harikrishnan N, Gejalakshmi S, Kayalvizhi S, Hemamalini Baskaran, Priyanka J, Mohan Kumar A i Sriram GM. "Novel herbs and drugs for endometriosis management: A review on current and futuristic therapies". International Journal of Research in Pharmaceutical Sciences 12, nr 2 (8.05.2021): 1404–14. http://dx.doi.org/10.26452/ijrps.v12i2.4699.
Pełny tekst źródłaCiesielska, Aleksandra, Aida Kusiak, Agata Ossowska i Magdalena Emilia Grzybowska. "Changes in the Oral Cavity in Menopausal Women—A Narrative Review". International Journal of Environmental Research and Public Health 19, nr 1 (27.12.2021): 253. http://dx.doi.org/10.3390/ijerph19010253.
Pełny tekst źródłaYu, Xinge, Angela C. Weyand i Jordan A. Shavit. "Surprisingly Rapid Onset of Estrogen-Induced Venous Thrombosis in an Animal Model". Blood 132, Supplement 1 (29.11.2018): 418. http://dx.doi.org/10.1182/blood-2018-99-120325.
Pełny tekst źródłaLopez-Munoz, E., N. Garcia-Hernandez, R. I. Penaloza-Espinosa, M. E. Gomez-Del Toro, G. Zarco-Espinosa, S. Barroso-Bravo, F. Salamanca-Gomez i D. J. Arenas-Aranda. "”BIK/NBK Gene Expression as a Possible Marker of Circulating Breast Cancer Cells in Blood“". Open Biomarkers Journal 4, nr 1 (14.10.2011): 8–14. http://dx.doi.org/10.2174/1875318301104010008.
Pełny tekst źródła